Bisphenol A: A Concise Review of Literature and a Discussion of Health and Regulatory Implications

Conclusion: Recent evidence suggests that low-doses of endocrine disruptors, such as BPA, could have profound effects in breast development and cancer risk. Recent studies in murine models suggest that BPA could contribute to breast oncogenesis via several pathways. The position of regulators should shift accordingly to safeguard the public interest.
Source: In Vivo - Category: Research Authors: Tags: Reviews Source Type: research